Citations (13)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Qi Zhang, Yue-Xiang Ma, Zheng Dai, Bin Zhang, Shan-Shou Liu, Wen-Xiu Li, Chuan-Qing Fu, Qian-Mei Wang & Wen Yin. (2023) Tracking Research on Hemoglobin-Based Oxygen Carriers: A Scientometric Analysis and In-Depth Review. Drug Design, Development and Therapy 17, pages 2549-2571.
Read now
Read now
Thomas Ming Swi Chang. (2022) The role of artificial cells in the fight against COVID-19: deliver vaccine, hemoperfusion removes toxic cytokines, nanobiotherapeutics lower free radicals and pCO2 and replenish blood supply. Artificial Cells, Nanomedicine, and Biotechnology 50:1, pages 240-251.
Read now
Read now
Thomas Ming Swi Chang. (2019) ARTIFICIAL CELL evolves into nanomedicine, biotherapeutics, blood substitutes, drug delivery, enzyme/gene therapy, cancer therapy, cell/stem cell therapy, nanoparticles, liposomes, bioencapsulation, replicating synthetic cells, cell encapsulation/scaffold, biosorbent/immunosorbent haemoperfusion/plasmapheresis, regenerative medicine, encapsulated microbe, nanobiotechnology, nanotechnology. Artificial Cells, Nanomedicine, and Biotechnology 47:1, pages 997-1013.
Read now
Read now
Chen Guo & Thomas Ming Swi Chang. (2018) Long term safety and immunological effects of a nanobiotherapeutic, bovine poly-[hemoglobin-catalase-superoxide dismutase-carbonic anhydrase], after four weekly 5% blood volume top-loading followed by a challenge of 30% exchange transfusion. Artificial Cells, Nanomedicine, and Biotechnology 46:7, pages 1349-1363.
Read now
Read now
Semhar Ghirmai, Leif Bülow & Hiromi Sakai. (2018) In vivo evaluation of electron mediators for the reduction of methemoglobin encapsulated in liposomes using electron energies produced by red blood cell glycolysis. Artificial Cells, Nanomedicine, and Biotechnology 46:7, pages 1364-1372.
Read now
Read now
Thomas Ming Swi Chang. (2017) Translational feasibility of soluble nanobiotherapeutics with enhanced red blood cell functions. Artificial Cells, Nanomedicine, and Biotechnology 45:4, pages 671-676.
Read now
Read now
Articles from other publishers (7)
M. Hoq & T. M. S. Chang. (2023) Preliminary feasibility study using a solution of synthetic enzymes to replace the natural enzymes in polyhemoglobin-catalase-superoxide dismutase-carbonic anhydrase: effect on warm ischemic hepatocyte cell culture. Frontiers in Bioengineering and Biotechnology 11.
Crossref
Crossref
Yuzhu Bian & Thomas Ming Swi Chang. (2023) Nanobiotechnological basis of an oxygen carrier with enhanced carbonic anhydrase for CO2 transport and enhanced catalase and superoxide dismutase for antioxidant function. Frontiers in Bioengineering and Biotechnology 11.
Crossref
Crossref
Wentao Jiang, Ziyu Wu, Zheng Gao, Mimi Wan, Min Zhou, Chun Mao & Jian Shen. (2022) Artificial Cells: Past, Present and Future. ACS Nano 16:10, pages 15705-15733.
Crossref
Crossref
Chintan Savla & Andre F. Palmer. (2022) Lyophilized annelid mega-hemoglobin retains its’ quaternary structure and oxygen equilibrium properties after room temperature storage for over 6 months. PLOS ONE 17:2, pages e0263996.
Crossref
Crossref
Thomas Ming Swi Chang. 2022. Blood Substitutes and Oxygen Biotherapeutics. Blood Substitutes and Oxygen Biotherapeutics
199
206
.
Thomas Ming Swi Chang. 2022. Blood Substitutes and Oxygen Biotherapeutics. Blood Substitutes and Oxygen Biotherapeutics
99
115
.
Shengyang Jin, Zhibin Yang, Xuefeng Han & Facheng Li. (2021) Blood Impairs Viability of Fat Grafts and Adipose Stem Cells: Importance of Washing in Fat Processing. Aesthetic Surgery Journal 41:1, pages 86-97.
Crossref
Crossref